NCT05632900

Brief Summary

Endoscopic ultrasound guided drainage of WON with metal stent is the mainstay of WON management. But there are few complications related to BFMS , like bleeding due to vessel erosion, stent clogging , stent migration . This study is to assess, whether placing an anchoring DPS through the BFMS will decrease adverse events or not. There are only 2 retrospective studies till date ,comparing LAMS with coaxial stent vs LAMS alone. one study showed no significant decrease in adverse events , one study showed decrease in adverse events when DPS with LAMS . But there has been no prospective RCT to assess the utility of DPS to date

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 17, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 21, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 1, 2022

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
Last Updated

February 24, 2023

Status Verified

February 1, 2023

Enrollment Period

1.3 years

First QC Date

November 21, 2022

Last Update Submit

February 22, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adverse evens rates associated with both the groups ( stent clogging and stent migration, bleeding).

    To monitor the adverse events like bleeding, stent clogging and stent migration.

    4 weeks

Secondary Outcomes (3)

  • re-intervention rates

    4 weeks

  • Technical success rate

    4 weeks

  • Clinical success rate

    4 weeks

Study Arms (2)

NAGI BI-FLANGED METAL STENT WITH CO-AXIAL PLASTIC STENT FOR DRAINAGE OF WOPN.

EXPERIMENTAL

Endoscopic ultrasound guided drainage -Nagi Bi Flanged metal stent--16mm diameter 2cm long with co Axial double pig tail stent used for drainage of walled of necrosis. Intra and post prodecural complications will be noted, a plane CT screening abdomen will be performed with in 48 to 72 hours to document the size of collection.

Procedure: Endoscopic ultrasound guided drainage of walled off pancreatic necrosis

NAGI BI-FLANGED METAL STENT ALONE FOR DRAINAGE OF WOPN.

ACTIVE COMPARATOR

Endoscopic ultrasound guided drainage -Nagi Bi Flanged metal stent--16mm diameter 2cm long used for drainage of walled of necrosis. Intra and post prodecural complications will be noted, a plane CT screening abdomen will be performed with in 48 to 72 hours to document the size of collection.

Procedure: Endoscopic ultrasound guided drainage of walled off pancreatic necrosis

Interventions

It is Therapeutic procedure to treat walled off pancreatic necrosis.

NAGI BI-FLANGED METAL STENT ALONE FOR DRAINAGE OF WOPN.NAGI BI-FLANGED METAL STENT WITH CO-AXIAL PLASTIC STENT FOR DRAINAGE OF WOPN.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic Walled-off pancreatic necrosis (WON)
  • Eligible for EUS guided BFMS placement
  • Signed informed consent .
  • Age \>18 Years

You may not qualify if:

  • Types of pancreatic collections other than WON .
  • Drainage with stents other than BFMS
  • Previous attempts at drainage of WON
  • Coagulopathy (INR\>1.5) or thrombocytopenia(plc \<50000/cmm)- not correctable.
  • Pregnancy
  • Not willing to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr Rajesh Gupta

Hyderabad, Telangana, 500082, India

Location

Study Officials

  • Rajesh Dr Gupta, MBBS MD DM

    Asian Institute of Gastroenterology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

November 21, 2022

First Posted

December 1, 2022

Study Start

July 17, 2021

Primary Completion

October 22, 2022

Study Completion

December 20, 2022

Last Updated

February 24, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations